89bio Historical Financial Ratios

ETNB Stock  USD 8.00  0.03  0.37%   
89bio is presently reporting on over 93 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 0.74 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate 89bio Inc financial condition quickly.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 89bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About 89bio Financial Ratios Analysis

89bio IncFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate 89bio investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on 89bio financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across 89bio history.

89bio Financial Ratios Chart

At present, 89bio's Payables Turnover is projected to increase slightly based on the last few years of reporting. The current year's Graham Number is expected to grow to 25.44, whereas PTB Ratio is forecasted to decline to 0.74.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Income Quality

An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.
Most ratios from 89bio's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into 89bio Inc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 89bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At present, 89bio's Payables Turnover is projected to increase slightly based on the last few years of reporting. The current year's Graham Number is expected to grow to 25.44, whereas PTB Ratio is forecasted to decline to 0.74.

89bio fundamentals Correlations

0.95-0.40.18-0.721.00.19-0.910.030.830.780.210.560.460.21-0.98-0.09-0.990.860.350.950.86-0.470.850.810.95
0.95-0.260.15-0.660.950.15-0.920.060.860.920.080.360.350.08-0.950.03-0.910.840.090.950.84-0.270.970.951.0
-0.4-0.260.440.67-0.40.430.47-0.06-0.19-0.3-0.92-0.29-0.7-0.920.35-0.340.49-0.72-0.74-0.37-0.720.88-0.2-0.01-0.26
0.180.150.44-0.20.181.0-0.060.590.53-0.15-0.280.570.24-0.28-0.32-0.28-0.13-0.03-0.30.3-0.030.470.110.280.15
-0.72-0.660.67-0.2-0.72-0.210.68-0.59-0.79-0.58-0.71-0.72-0.93-0.70.79-0.40.73-0.9-0.25-0.82-0.90.41-0.63-0.54-0.66
1.00.95-0.40.18-0.720.19-0.910.030.830.780.210.560.460.21-0.98-0.09-0.990.860.350.950.86-0.470.850.810.95
0.190.150.431.0-0.210.19-0.070.60.53-0.15-0.270.580.25-0.27-0.32-0.28-0.13-0.03-0.30.31-0.030.460.110.280.15
-0.91-0.920.47-0.060.68-0.91-0.07-0.01-0.82-0.84-0.24-0.28-0.42-0.240.910.060.91-0.9-0.3-0.92-0.90.48-0.89-0.82-0.92
0.030.06-0.060.59-0.590.030.6-0.010.490.010.370.560.720.36-0.220.480.010.24-0.380.280.240.350.130.160.06
0.830.86-0.190.53-0.790.830.53-0.820.490.720.150.590.590.15-0.930.04-0.790.79-0.070.950.79-0.060.850.860.86
0.780.92-0.3-0.15-0.580.78-0.15-0.840.010.720.110.10.260.11-0.790.23-0.750.8-0.050.820.8-0.220.960.880.92
0.210.08-0.92-0.28-0.710.21-0.27-0.240.370.150.110.430.831.0-0.210.54-0.290.590.570.260.59-0.670.04-0.120.08
0.560.36-0.290.57-0.720.560.58-0.280.560.590.10.430.750.42-0.590.06-0.560.470.280.570.47-0.210.240.260.36
0.460.35-0.70.24-0.930.460.25-0.420.720.590.260.830.750.83-0.540.45-0.490.720.310.590.72-0.390.310.230.35
0.210.08-0.92-0.28-0.70.21-0.27-0.240.360.150.111.00.420.83-0.210.54-0.290.590.570.250.59-0.670.04-0.120.08
-0.98-0.950.35-0.320.79-0.98-0.320.91-0.22-0.93-0.79-0.21-0.59-0.54-0.210.040.96-0.88-0.21-0.99-0.880.34-0.88-0.86-0.95
-0.090.03-0.34-0.28-0.4-0.09-0.280.060.480.040.230.540.060.450.540.040.110.27-0.20.040.270.050.160.10.03
-0.99-0.910.49-0.130.73-0.99-0.130.910.01-0.79-0.75-0.29-0.56-0.49-0.290.960.11-0.88-0.45-0.93-0.880.56-0.8-0.75-0.91
0.860.84-0.72-0.03-0.90.86-0.03-0.90.240.790.80.590.470.720.59-0.880.27-0.880.370.91.0-0.580.80.690.84
0.350.09-0.74-0.3-0.250.35-0.3-0.3-0.38-0.07-0.050.570.280.310.57-0.21-0.2-0.450.370.160.37-0.94-0.09-0.190.09
0.950.95-0.370.3-0.820.950.31-0.920.280.950.820.260.570.590.25-0.990.04-0.930.90.160.9-0.310.910.870.95
0.860.84-0.72-0.03-0.90.86-0.03-0.90.240.790.80.590.470.720.59-0.880.27-0.881.00.370.9-0.580.810.690.84
-0.47-0.270.880.470.41-0.470.460.480.35-0.06-0.22-0.67-0.21-0.39-0.670.340.050.56-0.58-0.94-0.31-0.58-0.130.02-0.27
0.850.97-0.20.11-0.630.850.11-0.890.130.850.960.040.240.310.04-0.880.16-0.80.8-0.090.910.81-0.130.970.97
0.810.95-0.010.28-0.540.810.28-0.820.160.860.88-0.120.260.23-0.12-0.860.1-0.750.69-0.190.870.690.020.970.95
0.951.0-0.260.15-0.660.950.15-0.920.060.860.920.080.360.350.08-0.950.03-0.910.840.090.950.84-0.270.970.95
Click cells to compare fundamentals

89bio Account Relationship Matchups

89bio fundamentals Accounts

201920202021202220232024 (projected)
Ptb Ratio3.111.932.092.921.480.74
Book Value Per Share8.4512.626.274.367.544.77
Free Cash Flow Yield(0.0915)(0.12)(0.29)(0.18)(0.16)(0.17)
Operating Cash Flow Per Share(2.39)(2.87)(3.82)(2.33)(1.82)(1.91)
Capex To Depreciation8.182.10.80.110.080.076
Pb Ratio3.111.932.092.921.480.74
Free Cash Flow Per Share(2.41)(2.88)(3.82)(2.33)(1.82)(1.91)
Roic(0.3)(0.24)(0.62)0.6(0.28)(0.26)
Net Income Per Share(5.4)(3.08)(4.48)(2.93)(2.0)(2.1)
Payables Turnover0.01720.02910.01150.01920.03180.0334
Cash Per Share8.7819.3412.395.418.137.54
Pocfratio(10.98)(8.48)(3.42)(5.46)(6.15)(6.46)
Capex To Operating Cash Flow(0.00546)(0.002725)(8.21E-4)(8.6E-5)(3.1E-5)(3.3E-5)
Pfcf Ratio(10.93)(8.46)(3.42)(5.46)(6.15)(6.46)
Days Payables Outstanding21.2K12.6K31.6K19.0K11.5K10.9K
Income Quality0.440.930.850.790.910.62
Roe(0.64)(0.24)(0.72)(0.67)(0.27)(0.28)
Ev To Operating Cash Flow(7.32)(4.05)(1.71)(5.03)(3.92)(4.11)
Pe Ratio(4.87)(7.92)(2.91)(4.34)(5.59)(5.87)
Return On Tangible Assets(0.6)(0.23)(0.55)(0.52)(0.24)(0.25)
Ev To Free Cash Flow(7.28)(4.04)(1.71)(5.03)(3.92)(4.11)
Earnings Yield(0.21)(0.13)(0.34)(0.23)(0.18)(0.19)
Net Debt To E B I T D A1.634.131.460.352.151.18
Current Ratio17.025.918.297.9720.0410.9
Tangible Book Value Per Share8.4512.626.274.367.544.77
Graham Number32.0429.5525.1516.9618.425.44
Shareholders Equity Per Share8.4512.626.274.367.544.77
Capex Per Share0.01310.0078320.0031352.01E-45.6E-55.3E-5
Graham Net Net8.2518.8310.584.117.296.07
Enterprise Value Over E B I T D A(3.26)(3.79)(1.46)(4.09)(3.76)(3.95)
Price Earnings Ratio(4.87)(7.92)(2.91)(4.34)(5.59)(5.87)
Price Book Value Ratio3.111.932.092.921.480.74
Days Of Payables Outstanding21.2K12.6K31.6K19.0K11.5K10.9K
Price To Operating Cash Flows Ratio(10.98)(8.48)(3.42)(5.46)(6.15)(6.46)
Price To Free Cash Flows Ratio(10.93)(8.46)(3.42)(5.46)(6.15)(6.46)
Ebt Per Ebit2.151.01.01(1.0)0.910.95

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether 89bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of 89bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of 89bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on 89bio Inc Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 89bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 89bio. If investors know 89bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 89bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.96)
Return On Assets
(0.41)
Return On Equity
(0.73)
The market value of 89bio Inc is measured differently than its book value, which is the value of 89bio that is recorded on the company's balance sheet. Investors also form their own opinion of 89bio's value that differs from its market value or its book value, called intrinsic value, which is 89bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 89bio's market value can be influenced by many factors that don't directly affect 89bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 89bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 89bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 89bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.